Rx Health: Pharmaceutical marketers have entrusted us with their brands to help respond to their most pressing business and communications challenges and opportunities. Our experts have extensive experience supporting products throughout the product lifecycle. We have worked in virtually every therapeutic area and have grappled with some of the most exciting challenges in health care such as changing the treatment paradigm for insomnia, altering misperceptions about seeking treatment for urinary incontinence, launching a first-in-class birth control patch, and transforming a cholesterol drug’s standing in the market.
Clinical Study Support: Our international team has tackled a wide range of clinical study recruitment and retention challenges spanning various therapeutic areas. We provide a breadth of global services, including protocol review, market research, branding, copy and material development, customized site support and retention efforts. We also offer interactive services, advertising, call center coordination, advocacy and grassroots community outreach, media relations and medical community activities. As strategic communicators, our focus is on creating the right message and delivering it at the right time and place to motivate action. We are adept at creating a tailored approach to accelerate recruitment, maintain study participation and overcome the unique barriers every clinical study will face.
Consumer Health: In the early 1990’s we formed the first Consumer Health practice in the agency world, which specializes in marrying traditional health marketing with the strategies that the consumer product marketing arena demands. Our consumer-minded health experts work on a diverse group of consumer health brands. From handling the first ever Rx-to-OTC switch (Advil in 1984 -- the gold standard for future OTC switches) to generating attention for an allergy drug in a highly crowded market, we have repeatedly set the pace for how and why consumers make their decisions about their health and well being.
Health Policy and Public Affairs: Whether the debate is global, regional or local in scope, our specialists garner the legislative, third-party and general public support critical to a client’s success. We design and execute public affairs and issues management strategies around major debates in health and have a deep understanding of the regulatory environment. The team’s successes include influencing public policy about the aging population, heightening awareness about the business community’s contribution to HIV/AIDS research, showcasing the citizenship of pharmaceutical companies who are improving access to medications to the uninsured, raising awareness about the role of pharmacists, and influencing the tobacco control environment. This group also has extensive experience in helping clients achieve their reimbursement goals.
Life Sciences: We offer dedicated communications services to established and emerging biotechnology, biopharmaceuticals, specialty pharmaceuticals, biomedical research, medical devices, medical diagnostics, and health technology companies. The group has tackled high profile assignments like engaging in public education and media relations in support of stem cell research programs, engendering support for brain monitoring technology, and generating awareness about the first chemotherapeutic agent delivered directly into the brain. Our experts succeed in blending health and biomedical capabilities, as well as financial, media, interactive and editorial talent at any point along an organization’s or product’s life cycle.
Corporate Health: Our team is committed to protecting and strengthening a company’s relationships with -- and reputation among -- its key constituencies so as to increase shareholder value, engage employees, deepen customer loyalty, and align government and public interests. Whether minimizing a company’s trust deficit, transforming a health care company to a health caring company, creating a reputation advantage, or performing a re-branding and positioning campaign, our approach is based on the premise that a company’s reputation and its brands are increasingly interdependent and that the current business environment demands open and honest communications.
BioScience Communications: Edelman’s medical education and publishing specialty firm, BioScience Communications, helps transform scientific breakthroughs into everyday clinical practice. They deliver compelling strategies and educational programs for drugs, devices and technologies such as utilizing the internet to spur debate and dialogue and create accredited educational programs for health professionals, partnering with thought-leaders and advocates to provide peer-to-peer education on products or the disease state, and extending the reach of symposia or other educational programs by crafting journal supplements and CME monographs.